ELASTY® F Plus with Lidocaine – Cross-Linked HA Dermal Filler | 1 × 1ml

Product Overview

ELASTY® F Plus with Lidocaine is a professional cross-linked Hyaluronic Acid (HA) dermal filler developed for fine to moderate wrinkle correction, natural soft tissue augmentation, facial rejuvenation and subtle volume restoration.

Manufactured in South Korea, ELASTY® F Plus contains 24mg/ml cross-linked Hyaluronic Acid and 0.3% Lidocaine within a cohesive injectable gel designed to provide a balance of elasticity, tissue support and natural-looking correction.

ELASTY® F Plus is manufactured using PNET® – Preserved Natural Entanglement Technology, an advanced HA gel-structuring and cross-linking technology designed to preserve the natural entanglement of Hyaluronic Acid chains while creating a stable and cohesive injectable matrix.

Positioned as a medium-viscosity formulation within the ELASTY® dermal filler range, F Plus provides a versatile option where practitioners require greater tissue support than a very soft or superficial filler without moving to a firmer structural formulation intended primarily for substantial projection or deep facial contouring.

Potential professional treatment objectives include:

• Fine to moderate wrinkle correction

• Facial fold correction

• Natural soft tissue augmentation

• Subtle facial volume restoration

• Lip contouring and enhancement where appropriate

• Lower-face rejuvenation

• Facial contour refinement

• Correction of selected areas of volume loss

The cross-linked HA gel provides immediate physical correction following appropriate placement, while the hydrophilic properties of Hyaluronic Acid support moisture retention within the treated tissue.

The formulation also contains 0.3% Lidocaine, a local anaesthetic incorporated to help improve patient comfort during treatment.

Unlike non-cross-linked skin boosters or regenerative Polynucleotide products, ELASTY® F Plus is primarily a dermal filler designed to provide physical correction, soft tissue support and volume.

ELASTY® F Plus is intended strictly for use by appropriately qualified medical or aesthetic professionals trained in dermal filler procedures.

Pack Contents

Each pack contains:

• 1 × 1ml pre-filled syringe of ELASTY® F Plus

• Cross-Linked Hyaluronic Acid: 24mg/ml

• Lidocaine: 0.3%

• Sterile injection needles as supplied by the manufacturer

• Sterile, sealed professional-use packaging

Volume per Syringe: 1ml

Total Product Volume: 1ml

Always check the individual product packaging, needle specifications, manufacturer labelling and current Instructions for Use before administration.

Product Composition

Cross-Linked Hyaluronic Acid – 24mg/ml

ELASTY® F Plus contains 24mg/ml cross-linked Hyaluronic Acid within a professional injectable dermal filler gel.

Hyaluronic Acid is naturally present within human tissues and plays an important role in hydration and extracellular matrix function.

Cross-linking modifies the HA gel to increase its stability and persistence compared with non-cross-linked Hyaluronic Acid formulations.

Within ELASTY® F Plus, the cross-linked HA is designed to provide:

• Physical wrinkle correction

• Soft tissue support

• Subtle volume restoration

• Facial contour refinement

• Smooth tissue integration

• Natural-looking aesthetic correction

Its medium-viscosity characteristics provide a balance between flexibility and support.

Lidocaine – 0.3%

ELASTY® F Plus contains 0.3% Lidocaine.

Lidocaine is a local anaesthetic incorporated into the formulation to help reduce injection-related discomfort and improve patient comfort during professional treatment.

Patient assessment should include consideration of any known hypersensitivity or contraindications relevant to Lidocaine and other product components.

Highly Purified Hyaluronic Acid

ELASTY® dermal fillers are formulated using highly purified Hyaluronic Acid within a professional injectable gel matrix.

The HA formulation is designed to provide controlled physical correction following appropriate professional placement.

Cohesive Cross-Linked HA Gel Matrix

The gel structure is designed to balance:

• Elasticity

• Cohesion

• Tissue support

• Mouldability

• Controlled delivery

• Smooth tissue integration

These characteristics contribute to natural-looking correction while allowing the filler to accommodate normal facial movement.

PNET® – Preserved Natural Entanglement Technology

ELASTY® dermal fillers are manufactured using PNET® – Preserved Natural Entanglement Technology.

PNET® is an HA gel-structuring and cross-linking process designed to preserve the natural entanglement of Hyaluronic Acid chains while producing a stable and cohesive injectable gel matrix.

Preserved HA Chain Entanglement

The manufacturing process is designed to preserve the natural entanglement of HA chains while creating a stable cross-linked gel structure.

High Elasticity

Elasticity supports the gel's ability to respond to normal tissue movement while maintaining the intended correction.

This is particularly relevant in dynamic facial areas where excessive rigidity may compromise natural-looking movement.

Strong Cohesion

Cohesion helps maintain the integrity of the HA gel following appropriate placement and supports controlled integration within surrounding tissues.

Stable HA Matrix

The cross-linked gel structure is designed to provide greater persistence and stability than a non-cross-linked HA formulation.

Controlled Product Delivery

The cohesive characteristics of the gel are designed to support smooth and controlled product delivery during professional administration.

Natural-Looking Tissue Integration

The balance between elasticity and cohesion is intended to support smooth integration and refined aesthetic correction.

Medium-Viscosity HA Formulation

ELASTY® F Plus is positioned as a medium-viscosity formulation within the ELASTY® range.

This provides a versatile balance between:

• Softness

• Flexibility

• Tissue support

• Cohesion

• Volume

• Mouldability

Rather than being intended primarily for very superficial correction or substantial deep structural projection, F Plus provides a balanced option for treatments requiring moderate support and natural-looking correction.

Potential applications may therefore include appropriate facial wrinkles, folds, selected areas of soft tissue volume loss and subtle contour enhancement.

Fine to Moderate Wrinkle Correction

ELASTY® F Plus is designed for professional treatment planning where correction of fine to moderate wrinkles and facial folds is required.

Potential objectives may include:

• Softening selected facial wrinkles

• Improving appropriate facial folds

• Restoring smoother facial transitions

• Supporting age-related soft tissue changes

• Refining lower-face contours

• Providing natural-looking rejuvenation

The appropriate product and treatment approach should always be selected according to wrinkle depth, tissue characteristics, anatomy and desired degree of correction.

Soft Tissue Augmentation

In addition to wrinkle correction, ELASTY® F Plus may be used within professionally planned treatments where subtle soft tissue augmentation is required.

Potential objectives may include:

• Restoring selected areas of facial volume

• Improving facial contours

• Supporting soft tissue

• Improving facial balance

• Correcting appropriate asymmetry

• Providing subtle enhancement without excessive projection

The objective should remain proportionate to the patient's existing facial anatomy.

Lip Enhancement & Contour

Where supported by the manufacturer's current Instructions for Use and appropriate following professional assessment, ELASTY® F Plus may be considered for selected lip treatments.

Potential objectives may include:

• Lip contour refinement

• Subtle volume enhancement

• Improved definition

• Correction of selected asymmetry

• Restoration of age-related volume loss

• Improvement of appropriate perioral lines

Lip treatment should always be individually planned according to anatomy, tissue characteristics, existing proportions and the patient's desired outcome.

Key Benefits

• Professional cross-linked HA dermal filler

• 1 × 1ml pre-filled syringe

• Contains 24mg/ml Hyaluronic Acid

• Contains 0.3% Lidocaine

• Manufactured using PNET® technology

• Medium-viscosity HA gel formulation

• Balanced elasticity and cohesion

• Designed for fine to moderate wrinkle correction

• Supports natural-looking facial rejuvenation

• Provides soft tissue support

• Supports subtle volume restoration

• Helps improve selected facial folds

• Supports facial contour refinement

• Provides immediate physical correction

• Designed for smooth tissue integration

• Supports controlled product delivery

• Cross-linked formulation supports gel stability

• Formulated with highly purified Hyaluronic Acid

• Lidocaine-containing formulation supports treatment comfort

• Suitable for selected lip enhancement protocols where appropriate

• Suitable for selected lower-face rejuvenation treatments

• Suitable for practitioner-led soft tissue augmentation

• Intended strictly for appropriately qualified professional use

Common Treatment Areas

The supplied product information identifies potential treatment areas including:

• Nasolabial folds

• Moderate facial wrinkles

• Perioral lines

• Marionette region where clinically appropriate

• Selected forehead lines where clinically appropriate

• Cheek lines and facial folds

• Selected lip contouring and enhancement

• Lower-face rejuvenation

• Selected areas of facial volume loss

• Soft tissue augmentation

• Facial contour refinement

• Neck lines where clinically appropriate

Treatment-area recommendations may vary according to the manufacturer's current Instructions for Use and the individual product supplied.

Not every area will be appropriate for every patient.

Particular anatomical areas carry increased vascular or other procedural risks and require suitable practitioner competence.

Treatment suitability should therefore always be determined according to:

• Manufacturer-authorised indications

• Facial anatomy

• Vascular anatomy

• Tissue characteristics

• Wrinkle or fold depth

• Degree of volume loss

• Previous aesthetic treatments

• Practitioner competence

• Individual treatment objectives

Always follow the manufacturer's current Instructions for Use regarding approved indications, treatment depth, product placement, technique and volume.

ELASTY® F vs ELASTY® F Plus

ELASTY® F and ELASTY® F Plus should be treated as distinct product variants rather than assuming that their specifications are interchangeable.

ELASTY® F

Based on the standard F product information, this formulation is positioned towards:

• Finer correction

• Superficial to moderate wrinkles

• Delicate facial areas

• Subtle enhancement

• Natural-looking refinement

ELASTY® F Plus

F Plus contains:

• 24mg/ml cross-linked HA

• 0.3% Lidocaine

It is positioned as a versatile medium-viscosity formulation for:

• Fine to moderate wrinkles

• Facial folds

• Soft tissue augmentation

• Subtle volume restoration

• Facial rejuvenation

• Selected contour refinement

The addition of Lidocaine is intended to improve patient comfort during professional administration.

Practitioners should always check the exact packaging and current Instructions for Use because specifications should not automatically be transferred between standard and Plus variants.

ELASTY® F Plus vs Firmer Structural Fillers

ELASTY® F Plus provides tissue support and volume but should be differentiated from firmer fillers designed primarily for substantial projection or deep structural augmentation.

ELASTY® F Plus

Primarily positioned around:

• Wrinkle correction

• Moderate tissue support

• Soft tissue augmentation

• Subtle volume

• Natural facial rejuvenation

• Balanced flexibility and cohesion

Firmer Structural Fillers

These are generally selected where treatment objectives require greater:

• Projection

• Deep structural support

• Lifting capacity

• Shape retention

• Significant volume restoration

• Strong facial contour definition

Product selection should always be based on anatomy, authorised indications, rheological characteristics and treatment objectives.

ELASTY® F Plus vs Skin Boosters

ELASTY® F Plus should not be confused with a skin booster.

Non-Cross-Linked HA Skin Boosters

These products primarily focus on:

• Hydration

• Moisture retention

• Skin texture

• Elasticity

• General skin-quality improvement

ELASTY® F Plus

As a cross-linked HA dermal filler, F Plus is designed primarily for:

• Physical wrinkle correction

• Soft tissue augmentation

• Volume restoration

• Tissue support

• Facial contour refinement

Although Hyaluronic Acid has water-binding properties, the primary purpose of ELASTY® F Plus is physical aesthetic correction rather than superficial skin hydration.

Recommended Treatment Approach

ELASTY® F Plus should only be administered following comprehensive professional assessment.

The supplied information describes the following general treatment approach:

• Initial Treatment: Single treatment session

• Product Volume: Individually determined

• Treatment Technique: Selected according to treatment area, practitioner training and manufacturer guidance

• Treatment Depth: Determined according to anatomy, tissue characteristics and manufacturer guidance

• Review: Commonly approximately 2–4 weeks following treatment

• Additional Correction: May be considered following clinical reassessment where appropriate

• Maintenance: Individually determined according to product persistence, treatment area and treatment goals

This should not be interpreted as a universal treatment protocol.

The manufacturer's current Instructions for Use should always take precedence.

Professional Treatment Considerations

ELASTY® F Plus is intended for administration by appropriately qualified and trained medical or aesthetic professionals with suitable competence in HA dermal filler procedures.

Treatment planning should include:

• Comprehensive patient consultation

• Full medical history

• Detailed facial assessment

• Assessment of facial proportions

• Assessment of tissue characteristics

• Evaluation of vascular anatomy

• Review of previous aesthetic procedures

• Assessment of contraindications

• Consideration of Lidocaine-related contraindications or hypersensitivity

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Treatment depth, product volume, administration technique and distribution should always be determined according to individual anatomy, treatment objectives and the manufacturer's current Instructions for Use.

Results & Treatment Outcomes

ELASTY® F Plus provides an immediate physical correction following appropriate professional placement.

Depending upon the treatment area and objectives, potential outcomes may include:

• Smoother-looking facial wrinkles

• Improvement in selected facial folds

• Subtle volume restoration

• Improved soft tissue contours

• Improved lip definition where appropriate

• Improved facial balance

• Natural-looking facial rejuvenation

Initial treatment-related swelling may temporarily influence the appearance of the treated area.

The final aesthetic result becomes clearer as swelling resolves and the filler integrates within the surrounding tissue.

Results & Longevity

The supplied product information describes results as commonly lasting approximately:

6–12 months

This should be considered an approximate range rather than a guaranteed duration.

Individual longevity varies according to:

• Treatment area

• Product volume

• Treatment depth

• Injection technique

• Patient metabolism

• Facial movement

• Patient age

• Lifestyle factors

• Tissue characteristics

• Individual biological response

Highly mobile areas may demonstrate different persistence compared with less mobile treatment areas.

Maintenance treatment may subsequently be considered following appropriate professional reassessment.

Storage & Handling

ELASTY® F Plus should be stored and handled according to the manufacturer's current Instructions for Use and the information supplied with the original product.

To maintain product integrity:

• Keep the product within its original packaging until required.

• Follow manufacturer-specified storage conditions.

• Protect the product from inappropriate environmental exposure.

• Inspect the syringe and outer packaging before use.

• Check the batch number and expiry date.

• Verify product authenticity and traceability.

• Maintain appropriate aseptic handling procedures.

• Do not use if sterile packaging is damaged.

• Do not use if the syringe appears compromised.

• Do not use after the stated expiry date.

Each syringe is intended for single use according to the manufacturer's Instructions for Use.

Important Information

ELASTY® F Plus with Lidocaine is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.

Professional knowledge of the following is essential:

• Facial anatomy

• Vascular anatomy

• HA dermal filler techniques

• Appropriate treatment planes

• Patient selection

• Aseptic technique

• Lidocaine-containing injectable products

• Complication prevention

• Recognition of vascular compromise

• Emergency management

• Dermal filler complication management

Patient Assessment

Treatment should only proceed following:

• Full patient consultation

• Comprehensive medical history

• Detailed facial assessment

• Examination of the proposed treatment area

• Review of previous aesthetic treatments

• Assessment of contraindications

• Assessment of known allergies or hypersensitivities

• Consideration of Lidocaine-related contraindications

• Discussion of expected outcomes

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Contraindications & Precautions

The supplied product information does not provide a complete manufacturer-defined contraindication list.

Practitioners should consult the current ELASTY® F Plus Instructions for Use for the complete contraindications, warnings and precautions applicable to both the HA filler and Lidocaine-containing formulation.

Treatment should not proceed where product sterility, integrity, authenticity or traceability cannot be established.

Potential Treatment Reactions

Temporary effects associated with injectable HA filler treatment may include:

• Redness

• Swelling

• Bruising

• Tenderness

• Discomfort

• Localised firmness

• Temporary contour irregularity

The exact adverse-event profile should be confirmed from the manufacturer's current Instructions for Use.

Serious Dermal Filler Complications

Injectable dermal filler procedures can result in more significant complications, including infection, inflammatory reactions and vascular complications.

Inadvertent intravascular administration can result in vascular occlusion and serious tissue injury. Depending upon the anatomical area involved, vascular filler complications can have severe consequences.

Practitioners must therefore have appropriate knowledge of facial vascular anatomy and be competent in:

• Risk reduction

• Recognition of vascular compromise

• Appropriate emergency response

• Dermal filler complication management

Patients should receive appropriate written aftercare information and clear instructions regarding symptoms requiring urgent professional assessment.

Always consult the manufacturer's current Instructions for Use for complete information regarding indications, contraindications, warnings, precautions, administration and potential adverse events.

For appropriately qualified professional use only.